On June 2, a California court heard oral argument in the appeal filed by Monsanto involving the August, 2018 multi-million dollar verdict in a case brought against them and its parent company, Bayer AG. The case was filed by Dewayne Johnson, a groundskeeper suffering...
Litigation Update: Elmiron Linked to Serious Eye Injuries
Elmiron [Pentosan Polysulfate Sodium (PPS)] is a drug developed in 1996 by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals to treat interstitial cystitis, bladder pain and osteoarthritis. The drug has been linked to serious eye injuries including...
Litigation Update: Boy Scouts of America Bankruptcy Proceedings Accelerate
A general bar date has been set for filing claims in the Chapter 11 bankruptcy proceedings involving the Boy Scouts of America. In a telephonic hearing held on May 18, Judge Laurie Selber Silverstein of the U.S. Bankruptcy Court for the District of Delaware...
Data Tells Many Stories Behind the COVID-19 Impact on Nursing Homes
Data Analysis by: Robert Koehl, Verus' Analytics Manager and Jose Thomas, Verus' Senior Statistician The news is filled every day with pandemic-related statistics: number of new cases, number of deaths, number of recoveries and so on. But what’s the real story behind...
How Will J&J’s Move to Discontinue Baby Powder Sales Impact Its Ongoing Talc Litigation Now?
On May 19, 2020, Johnson & Johnson announced it is discontinuing North American sales of its talc-based baby powder, a product it has defended for decades in the face of lawsuits filed by consumers who say it caused cancer. This move likely would not have happened...
Litigation Update: J&J to Discontinue Sales of Baby Powder in North America
Even as the company continues to defend the safety of its flagship product, pharmaceutical giant Johnson & Johnson announced on Tuesday that it would discontinue selling its talc-based baby powder product in the U.S. Facing tens of thousands of lawsuits from...
Litigation Update: California Appeals Court Reinstates Thousands of Risperdal Cases Against Johnson & Johnson
On May 8, the California 2nd District Court of Appeals reinstated thousands of cases pending against drug manufacturer Johnson & Johnson involving the antipsychotic drug Risperdal. The March, 2017 lower court ruling in the Risperdal and Invega Products Liability...
Assessing the Potential for Successful COVID Insurance Claims
By Guest Author: Gagan Gupta Insurance Disputes Division | Paynter Law Ph: (844) 272-5435 | ggupta@paynterlaw.com Almost every state and local government across the country has entered “shelter in place” or shutdown orders in response to the COVID-19 pandemic....
Litigation Update: Zantac Leadership Is Selected
On Friday, May 8th, District Judge Robin Rosenberg, of the U.S. District Court for the Southern District of Florida, appointed 26 lawyers to a range of leadership positions to the Zantac MDL that was transferred to Florida last February. Initially, the Judge had...
Litigation Update: J&J Talc Trial Continue in Missouri and New Jersey
Talc manufacturer Johnson and Johnson recently found itself in courtrooms in both New Jersey and Missouri battling in cases filed by plaintiffs who claim that the company’s talc products contained asbestos and caused their ovarian cancers. Missouri On April 24, the...